KCM
NRX

Knoll Capital Management’s NEPHROGENEX INC COM NRX Stock Holding History

Knoll Capital Management’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,072
Closed -$41K – 20
2014
Q4 		$41K Sell
3,072
-46,928
-94% -$217K 0.02% 14
2014
Q3 		$234K Hold
50,000
– – 0.09% 12
2014
Q2 		$301K Hold
50,000
– – 0.13% 11
2014
Q1 		$412K Buy
+50,000
New +$510K 0.21% 12

Other funds holding NRX

RCP
Rho Capital Partners New York $20.4M AUM
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Knoll Capital Management's NRX Position: Q1 2015 in Review

Knoll Capital Management sold out of NEPHROGENEX INC COM (NRX) in Q1 2015, closing a stake of 3,072 shares — an estimated $41K sold.

Knoll Capital Management first reported a position in NRX in Q1 2014 and held it in 4 quarters. The position peaked at $412K in Q1 2014. 13 funds tracked by Wall St. Rank hold NRX as of Q1 2015.

  • Knoll Capital Management reported no remaining NEPHROGENEX INC COM position as of Q1 2015 after selling out during the quarter.
  • Knoll Capital Management sold 3,072 NEPHROGENEX INC COM shares in Q1 2015, an estimated $41K.
  • Knoll Capital Management first reported a position in NEPHROGENEX INC COM in Q1 2014 and held it in 4 quarters.
  • Knoll Capital Management's NEPHROGENEX INC COM position peaked at $412K in Q1 2014.
  • 13 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q1 2015.

Based on Knoll Capital Management's 13F filing for Q1 2015, filed 15 May 2015.